Nearly 80% of physicians say EMR is not worth the cost. Read post.

 

Editor's picks

Our reads for the weekend

March 30, 2012

The Daily Briefing editorial team highlights several studies and articles that got us talking this week.

This week was huge for health care fanatics as the federal health reform law went before the Supreme Court. Now that the oral arguments are over, experts and media pundits across the country are weighing in on what's ahead for the law.

  • The Advisory Board's Chas Roades outlines the five key takeaways from this week's arguments. More.
  • Ezra Klein, of the Washington Post's "Wonkblog," lists the three ways the Supreme Court could rule against the individual mandate. More.
  • Sarah Kliff, also of "Wonkblog," takes a behind-the-scenes look at what will happen at the Supreme Court between now and June, when the decision is expected to be announced. More.
  • The New Yorker's Ryan Lizza examines the potential future of the health law without the mandate. More.
  • The New York Times' Kevin Sack outlines the options for Congress and the White House if the high court strikes down the individual mandate. More.

In other health news this week:

One in three U.S. cancer deaths can be attributed to diet and physical activity habits, according to a report in Cancer. More.

Europeans consume 12.5 liters of pure alcohol per year, more than in any other part of the world, according to report from the World Health Organization and the European Commission. More.

This week in the New York Times, 23-year-old Suleika Jaouad launched “Life, Interrupted,” a weekly column chronicling her experiences dealing with cancer in her 20s. More

Defining death: NPR explains how a new method for obtaining transplant organs is raising ethical questions. More.

A 37-year-old man hugs his doctor after receiving the most extensive face transplant to date. Reuters has the amazing photos of the transformative procedure. More.

Some Susan G. Komen for the Cure races report fundraising, attendance declines following the Planned Parenthood controversy, according to the Wall Street Journal. More.

Comment Now

You must be logged in to comment

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague